APA (7th ed.) Citation

Gijsmant, H., Kramer, M., Sargent, J., Tuchman, M., Maczura-Wolfe, D., Polis, A., . . . Ferrari, M. (1997). Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine. Cephalalgia, 17(6), 647. https://doi.org/10.1046/j.1468-2982.1997.1706647.x

Chicago Style (17th ed.) Citation

Gijsmant, H., MS Kramer, J. Sargent, M. Tuchman, D. Maczura-Wolfe, A. Polis, J. Teall, G. Block, and MD Ferrari. "Double-blind, Placebo-controlled, Dose-finding Study of Rizatriptan (MK-462) in the Acute Treatment of Migraine." Cephalalgia 17, no. 6 (1997): 647. https://doi.org/10.1046/j.1468-2982.1997.1706647.x.

MLA (9th ed.) Citation

Gijsmant, H., et al. "Double-blind, Placebo-controlled, Dose-finding Study of Rizatriptan (MK-462) in the Acute Treatment of Migraine." Cephalalgia, vol. 17, no. 6, 1997, p. 647, https://doi.org/10.1046/j.1468-2982.1997.1706647.x.